Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer

Lignende værker

• First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis
  af: Landre, Thierry, et al.
  Udgivet: (2020)
• Impact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer
  af: Gao, Guanghui, et al.
  Udgivet: (2019)
• Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer
  af: Zhou, Juan, et al.
  Udgivet: (2021)
• Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first‐ or second‐line treatment of advanced gastric and gastro‐esophageal junction cancer
  af: Özdemir, Berna C, et al.
  Udgivet: (2019)
• Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
  af: Jiang, Tao, et al.
  Udgivet: (2020)